New insights into atypical Alzheimer's disease in the era of biomarkers
Jonathan Graff-Radford1, Keir X X Yong2, Liana G Apostolova3, Femke H Bouwman4, Maria Carrillo5, Bradford C Dickerson6, Gil D Rabinovici7, Jonathan M Schott2, David T Jones1,8, Melissa E Murray9
1Department of Neurology, Mayo Clinic, Rochester, MN, USA
2Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK
3Department of Neurology; Indiana University School of Medicine; Indianapolis, IN USA
4Alzheimer Center Amsterdam, Department of Neurology, Amsterdam University Medical Center, Amsterdam, Netherlands
5Alzheimer's Association Chicago IL USA
6Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
7Department of Neurology, Radiology, and Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA
8Department of Radiology, Mayo Clinic, Rochester, MN, USA
9Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
The Lancet Neurology
Tập 20
222-234
Thông tin tác giả